study of targeted therapy for her2-positive metastatic breast cancer
Published 5 years ago • 4K plays • Length 3:19Download video MP4
Download video MP3
Similar videos
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
2:25
what is her2-positive breast cancer? | dana-farber cancer institute
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
4:14
study of gdc-0084 with trastuzumab in her2-positive breast cancer with brain metastases
-
19:44
emerging biomarkers and novel therapies for esophageal cancer
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
0:59
treatment for early stage her2 breast cancer | dana-farber cancer institute
-
4:59
study of saci-io for hormone receptor positive metastatic breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
39:15
metastatic breast cancer forum 2018: clinical trials 101 | dana-farber cancer institute
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
1:00:41
research update for her2-positive mbc | 2023-2024 embrace mbc virtual forum series
-
1:25
asco23: patrick wen, md | dana-farber cancer institute
-
17:01
breast cancer genomics and precision cancer medicine | dana-farber cancer institute
-
2:27
developing drugs to target breast cancer: dr. ian krop | dana-farber cancer institute